Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Priority Technology | PRTH | 5. nov 2024 | 5.63 | +11.49 |
Privia Health Group | PRVA | 5. nov 2024 | 19.31 | +0.47 |
Pro-Dex | PDEX | 5. nov 2024 | 41.21 | +1.43 |
ProAssurance | PRA | 5. nov 2024 | 15.10 | +2.79 |
Procaps Group | PROC | 5. nov 2024 | 1.74 | -2.16 |
Procept BioRobotics | PRCT | 5. nov 2024 | 95.46 | -1.66 |
Processa Pharmaceuticals | PCSA | 5. nov 2024 | 1.10 | -0.89 |
Procore Technologies | PCOR | 5. nov 2024 | 67.07 | +0.69 |
Procter & Gamble | PG | 5. nov 2024 | 165.76 | +0.41 |
Professional Diversity Network | IPDN | 5. nov 2024 | 0.83 | -0.59 |
Proficient Auto Logistics | PAL | 5. nov 2024 | 8.78 | +4.52 |
Profire Energy | PFIE | 5. nov 2024 | 2.51 | 0.00 |
Profound Medical | PROF | 5. nov 2024 | 7.91 | -3.54 |
ProFrac A | ACDC | 5. nov 2024 | 6.72 | +7.69 |
PROG | PRG | 5. nov 2024 | 45.69 | +2.19 |
Progress Software | PRGS | 5. nov 2024 | 64.77 | +1.30 |
Progressive | PGR | 5. nov 2024 | 248.07 | +2.73 |
Progyny | PGNY | 5. nov 2024 | 15.79 | +4.22 |
ProKidney | PROK | 5. nov 2024 | 1.62 | +3.85 |
Prologis | PLD | 5. nov 2024 | 114.43 | +0.50 |
ProMIS Neurosciences | PMN | 5. nov 2024 | 1.02 | -5.56 |
PropertyGuru | PGRU | 5. nov 2024 | 6.62 | 0.00 |
ProPetro | PUMP | 5. nov 2024 | 7.25 | +2.98 |
ProPhase Labs | PRPH | 5. nov 2024 | 2.08 | -5.02 |
ProQR Therapeutics | PRQR | 5. nov 2024 | 3.58 | -1.38 |
PROS | PRO | 5. nov 2024 | 21.32 | +2.85 |
ProShares Bitcoin Strategy ETF | BITO | 5. nov 2024 | 18.73 | +3.37 |
Proshares Ultra FTSE Europe | UPV | 5. nov 2024 | 62.46 | +1.41 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | 5. nov 2024 | 82.01 | +7.16 |
Proshares Ultrashort FTSE Europe | EPV | 5. nov 2024 | 7.43 | -2.11 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.